ADMP - Adamis Pharmaceuticals Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts4444
Avg. Estimate-0.17-0.09-0.74-0.37
Low Estimate-0.22-0.2-0.93-0.66
High Estimate-0.060.02-0.640.09
Year Ago EPS-0.21-0.24-0.9-0.74
Revenue EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts4444
Avg. Estimate5.23M9.17M21.5M36.14M
Low Estimate4.44M5.1M16.64M27.48M
High Estimate6.42M15.75M27.6M47.6M
Year Ago Sales3.39M2.84M13.07M21.5M
Sales Growth (year/est)54.40%222.70%64.50%68.10%
Earnings History9/29/201712/30/20173/30/20186/29/2018
EPS Est.-0.16-0.15-0.19-0.19
EPS Actual-0.21-0.24-0.23-0.29
Difference-0.05-0.09-0.04-0.1
Surprise %-31.20%-60.00%-21.10%-52.60%
EPS TrendCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.17-0.09-0.74-0.37
7 Days Ago-0.17-0.09-0.74-0.37
30 Days Ago-0.17-0.09-0.74-0.37
60 Days Ago-0.17-0.09-0.74-0.37
90 Days Ago-0.19-0.11-0.7-0.39
EPS RevisionsCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesADMPIndustrySectorS&P 500
Current Qtr.19.00%N/AN/A0.48
Next Qtr.62.50%N/AN/A0.40
Current Year17.80%N/AN/A0.21
Next Year50.00%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A